Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Perinatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/jp.2010.62PMID 20505743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.

  2010cited by this paper
• Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.

  2010cited by this paper
• Magnesium sulphate versus lytic cocktail for eclampsia.

  2010cited by this paper
• Fetal Reversed Constrictive Effect of Indomethacin and Postnatal Delayed Closure of the Ductus Arteriosus following Administration of Transplacental Magnesium Sulfate in Rats

  2009cited by this paper
• In defense of magnesium sulfate.

  2009cited by this paper
• Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants

  2007cited by this paper
• Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor

  2006cited by this paper
• Patent ductus arteriosus: pathophysiology and management

  2006cited by this paper
• Magnesium Sulfate Tocolysis: Time to Quit

  2006cited by this paper
• Magnesium sulfate: the first-line tocolytic.

  2005cited by this paper
• Effects of magnesium on prostacyclin synthesis and intracellular free calcium concentration in vascular cells.

  2004cited by this paper
• Magnesium sulfate for preeclampsia.

  2003cited by this paper
• Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.

  2002cited by this paper
• Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants.

  2001cited by this paper
• Antenatal magnesium sulphate exposure is associated with prolonged parathyroid hormone suppression in preterm neonates

  2001cited by this paper
• Anticonvulsants for women with pre-eclampsia.

  2000cited by this paper
• Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants.

  2000cited by this paper
• Developmental change in magnesium sulfate-induced relaxation of rabbit pulmonary arteries.

  1999cited by this paper
• The control of labor.

  1999cited by this paper
• Extracellular Mg2+ inhibits capacitative Ca2+ entry in vascular smooth muscle cells.

  1997cited by this paper
• Serum levels of magnesium at birth related to complications of immaturity

  1997cited by this paper
• Mechanisms of oxygen-induced contraction of ductus arteriosus isolated from the fetal rabbit.

  1993cited by this paper
• Magnesium regulates intracellular free ionized calcium concentration and cell geometry in vascular smooth muscle cells.

  1992cited by this paper
• Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study.

  1984cited by this paper
• Neonatal hypermagnesemia: effect on parathyroid hormone and calcium homeostasis.

  1980cited by this paper
• The response of the isolated ductus arteriosus to oxygen and anoxia

  1963cited by this paper

• Predictive model of ibuprofen treatment failure in very preterm infants with patent ductus arteriosus using machine learning techniques

  2025cites this paper
• Assessment of the relationship between serum magnesium levels, patent ductus arteriosus, and other neonatal morbidities: a retrospective observational study

  2025cites this paper
• An interpretable machine-learning model for predicting the efficacy of nonsteroidal anti-inflammatory drugs for closing hemodynamically significant patent ductus arteriosus in preterm infants

  2023cites this paper
• Fluid and electrolyte management in preterm infants with patent ductus arteriosus

  2022cites this paper
• Effects of antenatal magnesium sulfate use for neuroprotection on cardiorespiratory complications during the early neonatal period in preterm infants

  2021cites this paper
• Understanding the pathobiology in patent ductus arteriosus in prematurity—beyond prostaglandins and oxygen

  2019cites this paper
• Çok düşük doğum ağırlıklı prematürelerde antenatal magnezyum sülfat kullanımının patent duktus arteriozusa etkisi

  2019cites this paper
• Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis

  2019cites this paper
• Genetic Basis of Patent Ductus Arteriosus

  2019cites this paper
• Indomethacin Dosing and Constriction of the Ductus Arteriosus During Open Fetal Surgery for Myelomeningocele Repair

  2018cites this paper
• Serum Magnesium Levels in Preterm Infants Are Higher Than Adult Levels: A Systematic Literature Review and Meta-Analysis

  2017cites this paper
• Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies

  2016cites this paper
• PREVENCIÓN PRENATAL DE DAÑO NEUROLÓGICO EN PREMATURO EXTREMO

  2016cites this paper
• Necesidad de reanimación en prematuros menores de 32 semanas expuestos a sulfato de magnesio para neuroprotección fetal

  2016influential citation
• Nutrition in Bronchopulmonary Dysplasia: In the NICU and Beyond

  2016cites this paper
• [Need for resuscitation in preterm neonates less than 32 weeks treated with antenatal magnesium sulphate for neuroprotection].

  2016cites this paper
• Effects of Antenatal Magnesium Exposure on Intestinal Blood Flow and Outcome in Preterm Neonates

  2015cites this paper
• Patent Ductus Arteriosus

  2012cites this paper
• The Role of Magnesium Sulfate in the Prevention of Cerebral Palsy

  2012cites this paper